Entering text into the input field will update the search result below

Dr. Leonardo Mirandola is the new Chief Scientific Officer of Kiromic biopharma

Jul. 12, 2022 8:38 AM ETKiromic BioPharma, Inc. (KRBP)By: Deepa Sarvaiya, SA News Editor
  • Kiromic BioPharma (NASDAQ:KRBPappoints Leonardo Mirandola, Ph.D., as Chief Scientific Officer, effective immediately. 
  • Dr. Mirandola has served as the Company’s Vice President of R&D and Clinical Translation since September 2021 and his previous role was Head of Clinical Translation from 2020 to 2021.
  • He joined the company in 2016 as Executive Director of R&D.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.